We all are aware of this but parsons gave reasons for over turning himself. Are those reasons valid?
Although fda approval was not needed to stock pile, to continue to receive financing to develop 246 a clear pathway to fda approval was needed correct? I do remember at some time that became a very speculative to situation as to whether that pathway was defined. Wasn't a special meeting held to try to nail down pathway? This again was from the competition challenging siga? I think cbli had their pathway halted and stock got killed. If I remember this right there was a lot of speculation here?
Wait until 2016 or 2017? Didn't parsons experts model say pip would have delivered 29 million courses by 2012? Thought date of delivery would be more precise. Time between contracts with fickle client really cuts into profits. Maybe it'd too speculative to say profit is a guarantee?
So now chimerix is in the mix. Unforseen competition adding speculation. And now the % of people who may have adverse reactions to vaccine due to compromised immune system can get divided because sole source was successfully challenged. Seems like a lot of speculation not accounted for in parsons opinion.
Other thing I find interesting is some say why doesn't pip buy siga? Or siga buy pip? Or a big pharma buy both? The reason is it is too speculative that there will never be another contract for 246. But the award may be greater than siga has sold to date. Parsons is lost.
I really do appreciate the dialogue. And I thank you. I gave my reasons to believe it is speculation. Parsons could have easily went into future citing canceled options on contract to show how depending on one client could have just as easily resulted in no contract. Putting siga in bk may not be in pips best interest. He also threw out ROW to make his # of courses more realistic. Baliban his expert had 29 million courses being sold from 2008-2012. Some expert.
I also believe that too punitive is not justice. Interest seems unfair as siga had no choice but to wait for a terrible decision first time from parsons. Why doesn't he pay the interest for his first opinion and the length of time he took to finally get to this point.
I have a plan and understand the risk reward. You want to keep posting to make opinion right. That is your right. Where did you stand on promissory estoppel? Did you think that would be over turned?
No i believe expectation of reasonable time to sell 246 is speculative. I believe baliban # of courses to be sold by pip to be speculative also. I believe parsons pulled bits of information from the future and ignored others from baliban to fit his opinion. I do thank you for saving me from jumping in too quick. Your post yo wait for dip when lump sum # would come out helped. I believe it will go to SC.
I appreciate your posts and opinions. I just believe it is too speculative of an award. I do believe something is owed to pip. I also agree with you that when lump sum # comes out siga will dip. I would then consider stock price at that time. I think it will be appeal ed.
Did acambis have a history of supplying US govt? Did they have ability to manufacture the vaccine? Did siga in 2006 have manufacturing capabilities? Was acambis contract sole source? Was the threat of wmd as great in 2006 as it was in 2002? Why were there 6 calculations for damages by baliban?
Really believe the zip4pip is not true at this time. And a better buying opportunity probably may arise when lump sum figure comes out.